In this context, TAM receptors, particularly MerTK and Axl, are of interest because of their expression in lesional cells and their involvement in both efferocytosis and inflammation control4, 5, 6, 7, 11, both of which go awry in advanced atherosclerosis. The gene discussed is MERTK; the disease is atherosclerosis.